Comparative Study of the Effects of Atypical Antipsychotic Drugs on Plasma and Urine Biomarkers of Oxidative Stress in Schizophrenic Patients

Comparative Study of the Effects of Atypical Antipsychotic Drugs on Plasma and Urine Biomarkers of Oxidative Stress in Schizophrenic Patients

Anna Dietrich-Muszalska,1 Joanna Kolodziejczyk-Czepas,2 Pawel Nowak2 1Medical University of Lodz, Department of Biological Psychiatry and Neurophysiology, Lodz, Poland; 2University of Lodz, Department of General Biochemistry, Lodz, PolandCorrespondence: Anna Dietrich-MuszalskaDepartment of Biologica...

Full description

Bibliographic Details
Main Authors:	Dietrich-Muszalska A, Kolodziejczyk-Czepas J, Nowak P
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-02-01
Series:	Neuropsychiatric Disease and Treatment
Subjects:	schizophrenia antipsychotics f2-isoprostanes tac other oxidative markers
Online Access:	https://www.dovepress.com/comparative-study-of-the-effects-of-atypical-antipsychotic-drugs-on-pl-peer-reviewed-article-NDT

Similar Items

Atypical antipsychotics in the treatment of schizophrenia
by: Swiss Medical Weekly
Published: (2003-02-01)

Clozapine: A special case of an atypical antipsychotic
by: Elina Marinho
Published: (2024-04-01)

Atypical Antipsychotics Induced Metabolic Syndrome
by: Aysegul Demirel, et al.
Published: (2015-03-01)

Recent evidence and potential mechanisms underlying weight gain and insulin resistance due to atypical antipsychotics
by: Ana Maria Volpato, et al.
Published: (2013-09-01)

Treatment of antipsychotic-induced parkinsonism in schizophrenic patients
by: E. E. Vaiman, et al.
Published: (2021-08-01)

Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia
by: I. A. Vilyum, et al.
Published: (2018-08-01)

Metabolic disturbances in patients with paranoid schizophrenia treated with atypical antipsychotic drugs
by: Leonid Mikhaylovich Bardenshteyn, et al.
Published: (2010-06-01)

Hyperhomocysteinemia in Treatment with Atypical Antipsychotics is Independent of Metabolic Syndrome
by: Emre Sarandöl, et al.
Published: (2023-12-01)

Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review
by: Xu H, et al.
Published: (2019-07-01)

A comparison of depot and oral atypical antipsychotics in terms of metabolic syndrome markers
by: Demet Sağlam Aykut, et al.
Published: (2018-07-01)

Effect of Atypical Antipsychotic Medications on the Risk of Obstructive Sleep Apnea in Individuals With Schizophrenia
by: Habibolah Khazaie, et al.
Published: (2022-09-01)

Effects of zinc sulfate on schizophrenia symptoms in patients undergoing atypical antipsychotic pharmacotherapy
by: Forouzan Behrouzian, et al.
Published: (2022-01-01)

Anti-stress Properties of Atypical Antipsychotics
by: Alice Sanson, et al.
Published: (2020-10-01)

Metabolic and clinical effect of alpha-lipoic acid administration in schizophrenic subjects stabilized with atypical antipsychotics: A 12-week, open-label, uncontrolled study
by: Fiammetta Iannuzzo, et al.
Published: (2022-01-01)

Alteration of Serum Levels of Cytokines in Schizophrenic Patients before and after Treatment with Risperidone
by: Esfandiar Azizi, et al.
Published: (2019-06-01)

Comparison of antipsychotic prescribing practices following failure of antipsychotic monotherapy in the acute care setting
by: Kaitlyn Morgan, PharmD, BCPP, et al.
Published: (2023-01-01)

Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
by: Eiji Kirino
Published: (2017-11-01)

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
by: Sang Won Jeon, et al.
Published: (2017-10-01)

Pharmacoeconomic comparison of ziprasidone with other atypical oral antipsychotic agents in schizophrenia
by: Andrea Fagiolini, et al.
Published: (2011-11-01)

Influence of the use of atypical antipsychotics in metabolic syndrome
by: P Doménech-Matamoros
Published: (2020-07-01)

The influence of typical and atypical antipsychotics on neurocognitive functions in patients with psychotic disorders
by: Javorac Jovan M., et al.
Published: (2019-01-01)

Treatment Responses of Cognitive Function and Plasma Asymmetric Dimethylarginine to Atypical Antipsychotic in Patients With Schizophrenia
by: Zhi-min Yu, et al.
Published: (2019-01-01)

The effect of antipsychotic medication and the associated hyperprolactinemia as a risk factor for periodontal diseases in schizophrenic patients: a cohort retrospective study
by: Rania Shalaby, et al.
Published: (2023-10-01)

Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics
by: Anastasiia S. Boiko, et al.
Published: (2021-05-01)

Unlocking the molecular mechanisms of antipsychotics – a new frontier for discovery
by: Heather Bowling, et al.
Published: (2016-07-01)

The effects of therapeutic concentrations of ziprasidone on free thiols and thiobarbituric acid reactive substances levels in human plasma – in vitro studies
by: Anna Dietrich-Muszalska, et al.
Published: (2012-12-01)

The assessment of amisulpride effects in vitro on plasma thiol groups
by: Anna Dietrich-Muszalska, et al.
Published: (2012-12-01)

Neuropsychological assessment and treatment possibilities of cognitive deficit in schizophrenic patients
by: Totić-Poznanović Sanja, et al.
Published: (2012-01-01)

Polypharmacy Management of Antipsychotics in Patients with Schizophrenia
by: Hiroyuki Kamei
Published: (2022-11-01)

Antipsychotics for elderly with psychosis: Deprescribe or continue?
by: P. Mohr
Published: (2021-04-01)

Hormonal alterations due to antipsychotic-related hyperprolactinemia
by: A.L. Montejo, et al.
Published: (2022-06-01)

Identification of Antipsychotic Side Effects with Glassgow Antipsychotic Side-Effect Scale (GASS)
by: Dita Hasni, et al.
Published: (2020-08-01)

Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
by: Olga Płaza, et al.
Published: (2022-12-01)

The effects of antipsychotic drugs on depression level in patients with schizophrenia: clozapine vs. other atypical antipsychotics
by: Hülya Ertekin, et al.
Published: (2016-08-01)

The effects of therapeutic concentrations ofamisulpride andrisperidone on human plasma lipid peroxidation – invitro studies
by: Anna Dietrich-Muszalska, et al.
Published: (2011-09-01)

Effectiveness of antipsychotics in schizophrenia with comorbid substance use disorder
by: M. Lähteenvuo, et al.
Published: (2021-04-01)

EFFECT OF TYPICAL AND ATYPICAL ANTIPSYCHOTICS ON PLASMA PROLACTIN LEVELS IN SCHIZOPHRENIA
by: Muhammad Sami Bilal, et al.
Published: (2015-01-01)

The Effect of Menopause on Antipsychotic Response
by: Alexandre González-Rodríguez, et al.
Published: (2022-10-01)

The efficacy, acceptability, and safety of five atypical antipsychotics in patients with first-episode drug-naïve schizophrenia: a randomized comparative trial
by: Congjie Wang, et al.
Published: (2017-12-01)

Combination treatment with second generation antipsychotics other than clozapine
by: C. Schmidt-Kraepelin
Published: (2021-04-01)